Medicare Enrolled
Dr. Qaiser Niaz, MD
Internal Medicine · Hayward, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Niaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Niaz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Niaz
Dr. Qaiser Niaz is an internal medicine specialist in Hayward, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Niaz performed 116,045 Medicare services across 2,782 unique beneficiaries.
Between the years covered by Open Payments, Dr. Niaz received a total of $11,728 from 81 pharmaceutical and/or device companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Niaz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$11,728 industry payments
Medicare Practice Summary
Medicare Utilization ↗116,045
Medicare services
Top 0% in CA for internal medicine
2,782
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,802 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
22,350 | $0 | $7 |
| Pembrolizumab injection (Keytruda) | 20,400 | $43 | $146 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,770 | $0 | $7 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,750 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
8,681 | $6 | $29 |
| Denosumab injection (Prolia/Xgeva) | 7,980 | $18 | $65 |
| Pemetrexed injection, 10 mg Administration of a 10 mg dose of pemetrexed medication via injection. |
7,022 | $11 | $217 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,240 | $6 | $45 |
| MRI contrast dye injection (gadobutrol) | 4,050 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,340 | $0 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,480 | $1 | $106 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,152 | $7 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,055 | $8 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
757 | $14 | $84 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
697 | $30 | $145 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
663 | $113 | $355 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
576 | $83 | $872 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
449 | $79 | $368 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
400 | $2 | $225 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
393 | $138 | $659 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
260 | $20 | $89 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
208 | $167 | $462 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
206 | $56 | $243 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
188 | $1 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
187 | $72 | $248 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
174 | $6 | $377 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
146 | $66 | $294 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
137 | $29 | $147 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
133 | $69 | $321 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
120 | $1,686 | $6,763 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
115 | $59 | $271 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 112 | $281 | $1,134 |
| New patient office visit, complex (60-74 min) | 100 | $187 | $610 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
95 | $178 | $933 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
93 | $312 | $1,374 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
82 | $155 | $501 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
79 | $25 | $110 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
76 | $1 | $33 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
65 | $1 | $17 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
64 | $16 | $91 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
63 | $30 | $138 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
58 | $71 | $186 |
| MRI of abdomen with and without contrast An MRI scan of the abdomen using contrast dye before and after administration to create detailed images of internal structures. |
24 | $336 | $2,668 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $108 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $145 | $442 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
13 | $60 | $247 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.3% high complexity
82.9% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,728
Total received (2018-2024)
Avg $1,675/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
539
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,539 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$190 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,031
2023
$2,530
2022
$984
2021
$1,080
2020
$769
2019
$1,265
2018
$1,070
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$436
Novartis Pharmaceuticals Corporation
$386
Janssen Biotech, Inc.
$286
AstraZeneca Pharmaceuticals LP
$285
E.R. Squibb & Sons, L.L.C.
$244
PFIZER INC.
$241
Takeda Pharmaceuticals U.S.A., Inc.
$234
Celgene Corporation
$198
Astellas Pharma US Inc
$170
ABBVIE INC.
$161
Eisai Inc.
$157
SpringWorks Therapeutics, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$109
US Oncology Corporate, Inc.
$99
PROGENICS PHARMACEUTICALS, INC.
$86
ARRAY BIOPHARMA INC
$78
Coherus Biosciences Inc.
$73
Daiichi Sankyo Inc.
$62
Pharmacosmos Therapeutics Inc.
$60
Janssen Pharmaceuticals, Inc
$60
GlaxoSmithKline, LLC.
$59
GENZYME CORPORATION
$54
PUMA BIOTECHNOLOGY, INC.
$52
Lilly USA, LLC
$44
SOBI, INC
$38
Amgen Inc.
$32
Aveo Pharmaceuticals, Inc.
$27
TAIHO ONCOLOGY, INC.
$24
Genmab U.S., Inc.
$24
TerSera Therapeutics LLC
$23
Incyte Corporation
$22
SERVIER PHARMACEUTICALS LLC
$21
Kite Pharma, Inc.
$18
Rigel Pharmaceuticals, Inc.
$18
Tempus AI, Inc
$17
EMD Serono, Inc.
$16
Top 3 companies account for 27.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$908
Novartis Pharmaceuticals Corporation
$857
E.R. Squibb & Sons, L.L.C.
$838
AstraZeneca Pharmaceuticals LP
$823
PFIZER INC.
$677
Merck Sharp & Dohme LLC
$675
Takeda Pharmaceuticals U.S.A., Inc.
$550
Astellas Pharma US Inc
$522
Celgene Corporation
$465
Merck Sharp & Dohme Corporation
$447
Amgen Inc.
$391
Eisai Inc.
$279
Genentech USA, Inc.
$254
Pharmacyclics LLC, An AbbVie Company
$222
Lilly USA, LLC
$189
Daiichi Sankyo Inc.
$176
ABBVIE INC.
$161
Seattle Genetics, Inc.
$159
Kite Pharma, Inc.
$158
Seagen Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$145
GlaxoSmithKline, LLC.
$137
Coherus Biosciences Inc.
$126
Pharmacosmos Therapeutics Inc.
$125
SpringWorks Therapeutics, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$109
TESARO, Inc.
$101
US Oncology Corporate, Inc.
$99
PROGENICS PHARMACEUTICALS, INC.
$86
Incyte Corporation
$83
ARRAY BIOPHARMA INC
$78
GENZYME CORPORATION
$77
Acrotech Biopharma LLC
$75
Janssen Pharmaceuticals, Inc
$74
Sumitomo Pharma America, Inc.
$53
Rigel Pharmaceuticals, Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$52
CTI BioPharma Corp.
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Myriad Genetic Laboratories, Inc.
$49
EISAI INC.
$45
Foundation Medicine, Inc.
$45
Alexion Pharmaceuticals, Inc.
$45
Dexcom, Inc.
$45
TAIHO ONCOLOGY, INC.
$43
Gilead Sciences, Inc.
$40
SOBI, INC
$38
Novo Nordisk Inc
$38
Mylan Institutional Inc.
$36
Dendreon Pharmaceuticals LLC
$34
INSYS Therapeutics Inc
$33
Sobi, Inc
$33
Pharmacyclics LLC, an AbbVie Company
$32
EMD Serono, Inc.
$31
Octapharma USA, Inc.
$30
Stemline Therapeutics Inc.
$27
Aveo Pharmaceuticals, Inc.
$27
Apellis Pharmaceuticals, Inc.
$26
Global Blood Therapeutics, Inc.
$24
Verastem, Inc.
$24
ImmunoGen, Inc.
$24
Genmab U.S., Inc.
$24
TerSera Therapeutics LLC
$23
Kyowa Kirin, Inc.
$23
Dova Pharmaceuticals
$23
Jazz Pharmaceuticals Inc.
$21
SERVIER PHARMACEUTICALS LLC
$21
Myovant Sciences Inc.
$20
BeiGene USA, Inc.
$19
Heron Therapeutics, Inc.
$18
Endo Pharmaceuticals Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
HOLOGIC INC
$18
AbbVie Inc.
$18
Clovis Oncology, Inc.
$18
Array BioPharma Inc.
$18
Tempus AI, Inc
$17
Sirtex Medical Inc
$16
Taiho Oncology, Inc.
$15
Medtronic, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 22.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALUNBRIG · Abraxane · Alecensa · Aliqopa · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Braftovi · CALQUENCE · CARVYKTI · CREON · Contura · Copiktra · DARZALEX · DOPTELET · Dexcom G6 Transmitter · Doptelet · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · HEMADY · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JANUVIA · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NATESTO · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGIVRI · OGSIVEO · OPDIVO · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Prolia · REBLOZYL · RYBELSUS · RYBREVANT · Revlimid · Rezlidhia · Rubraca · Rybelsus · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SUBSYS · SYNCHROMEDII · SYNDROS · Stivarga · Sustol · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
4,443
Per 100K population
269.0
County median income
$126,240
Nearest hospital
ST ROSE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Niaz is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Niaz experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Niaz performed 22,350 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Niaz receive payments from pharmaceutical companies?
Yes. Dr. Niaz received a total of $11,728 from 81 companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Niaz's costs compare to other internal medicine physicians in Hayward?
Dr. Niaz's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Niaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Hayward
Browse internal medicine physicians in Hayward ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology